Potent inhibitors of phosphatidylinositol 3 (PI3) kinase that have antiproliferative activity only when delivered as prodrug forms

NJ O'Brien, S Amran, J Medan, B Cleary…

文献索引：O'Brien, Nathan J.; Amran, Syazwani; Medan, Jelena; Cleary, Ben; Deady, Leslie W.; Jennings, Ian G.; Thompson, Philip E.; Abbott, Belinda M. ChemMedChem, 2013 , vol. 8, # 6 p. 914 - 918

全文：HTML全文

被引用次数: 3

摘要

Phosphatidylinositol 3 kinase (PI3K) enzymes have emerged as important therapeutic targets in recent years as PI3K isoforms are involved in numerous cell signaling pathways associated with a range of diseases.[1] Prominent among these is cancer, with numerous instances of genetic mutations that enhance the PI3K signal identified, such as mutations in the PI3KCA gene that expresses PI3Ka, and downregulation of phosphatase PTEN that ...